The donor-derived cell-free DNA test was developed by the National Institutes of Health/National Heart Blood and Lung Institute.
An artificial intelligence solution that can identify precancerous changes in a woman’s cervix, comes on the heels of a Mayo Clinic Study that shows the percentage of women who are screened for cervical cancer could be far lower than national data suggests.
A team of researchers at the Imperial College London have developed a process known as known as traction force-activated payloads (TrAPs), that could have a significant impact on the body’s natural ability to heal.
A study from Mayo Clinic researchers shows less than two thirds of women ages 30 to 65 were up-to-date with cervical cancer screenings in 2016, which is below the 81% screening compliance rate self-reported in the 2015 National Health Interview Survey.
These companies, devices, and concepts struggled in 2018 – some even past the point of recovery. Here is a list of those with the greatest losses this year.
These companies have risen above the rest in 2018. Which one do you think deserves to wear the crown?
MD+DI asked for reader feedback on the recently-released Netflix documentary, The Bleeding Edge, and our community did not disappoint.
New clinical trial data shows the HeartLogic Diagnostic suite of sensors significantly expanded the ability of a baseline blood test to identify when patients were at an elevated risk of a heart failure event.